Modern approach to hepatocellular carcinoma

Current Gastroenterology Reports

Volumn 13, Issue 1, 2011, Pages 49-55

  Sherman, Morris ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Cirrhosis; Hepatitis C; Hepatocellular carcinoma; Surveillance

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; SORAFENIB; WNT PROTEIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SUSCEPTIBILITY; CLASSIFICATION ALGORITHM; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ECHOGRAPHY; GENE IDENTIFICATION; GENE MUTATION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METASTASIS; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; NEOPLASM STAGING; POPULATION SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS;

EID: 79551506192     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-010-0163-7     Document Type: Article

References (36)

1. CS Wang WJ Yao TT Chang, et al. 2009 The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses Cancer Epidemiol Biomarkers Prev. 18 7 2054 60 1:CAS:528:DC%2BD1MXosFWjsrg%3D 10.1158/1055-9965.EPI-08-1131 19549812
2. BJ Veldt W Chen EJ Heathcote, et al. 2008 Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus Hepatology. 47 6 1856 62 10.1002/hep.22251 18506898 (Pubitemid 351945553)
3. E Bugianesi N Leone E Vanni, et al. 2002 Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology. 123 1 134 40 10.1053/gast.2002.34168 12105842 (Pubitemid 34747534)
4. J Polesel A Zucchetto M Montella, et al. 2009 The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma Ann Oncol. 20 2 353 7 1:STN:280:DC%2BD1M7jtlWjtA%3D%3D 10.1093/annonc/mdn565 18723550
5. HD Tung JH Wang PL Tseng, et al. 2010 Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies Am J Gastroenterol. 105 3 624 31 10.1038/ajg.2009.711 20051944
6. V Paradis S Zalinski E Chelbi, et al. 2009 Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis Hepatology. 49 3 851 9 10.1002/hep.22734 19115377
7. S Yatsuji E Hashimoto M Tobari, et al. 2009 Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C J Gastroenterol Hepatol. 24 2 248 54 1:CAS:528:DC%2BD1MXjslKksr0%3D 10.1111/j.1440-1746.2008.05640.x 19032450
8. AS Lok LB Seeff TR Morgan, et al. 2009 Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease Gastroenterology 136 1 138 48 1:CAS:528:DC%2BD1MXht1Cqsrk%3D 10.1053/j.gastro.2008.09.014 18848939 In this paper, the risk of noncirrhotic patients with chronic hepatitis C is documented, and a risk score developed that helps predict who among patients with chronic hepatitis C are likely to develop HCC
9. KL Andersson JA Salomon SJ Goldie, et al. 2008 Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis Clin Gastro Hepatol 6 1418 1424 10.1016/j.cgh.2008.08.005 There are many cost-efficacy analyses on HCC surveillance. Most have faults that make the conclusion doubtful. This analysis most closely mirrors real life, and the conclusions are likely to be correct. In particular, it shows that surveillance with CT or MRI is hugely cost-ineffective
10. K Nouso H Tanaka S Uematsu, et al. 2008 Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances J Gastro Hepatol 23 437 444 10.1111/j.1440-1746.2007.05054.x (Pubitemid 351342062)
11. FP Sarasin E Giostra A Hadengue 1996 Cost effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with Child Pugh class A cirrhosis Am J Med 101 422 434 1:STN:280:DyaK2s%2Fislektw%3D%3D 10.1016/S0002-9343(96)00197-0 8873514 (Pubitemid 26392861)
12. D Patel N Terrault F Yao, et al. 2005 Cost-Effectiveness of Hepatocellular Carcinoma Surveillance in Patients With Hepatitis C Virus-Related Cirrhosis Clin Gastro Hepatol 3 75 84 10.1016/S1542-3565(04)00443-4 (Pubitemid 40092947)
13. OS Lin ED Keeffe GD Sanders, et al. 2004 Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C Aliment Pharmacol Ther 19 1159 1172 1:STN:280:DC%2BD2c3lsVCruw%3D%3D 10.1111/j.1365-2036.2004.01963.x 15153169 (Pubitemid 38746259)
14. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 5 1208 1236 10.1002/hep.20933 16250051 (Pubitemid 43112690)
15. MF Yuen Y Tanaka DY Fong, et al. 2009 Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B J Hepatol. 5 80 8 10.1016/j.jhep.2008.07.023
16. HI Yang M Sherman J Su, et al. 2010 Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection J Clin Oncol 28 2437 44 10.1200/JCO.2009.27.4456 20368541 This paper provides an HCC risk nomogram that can be applied with clinical data available to any physician that helps determine whether a patient is at risk for the development of HCC, and who should therefore be entered into a surveillance program
17. AS Lok RK Sterling JE Everhart, et al. 2010 Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma Gastroenterology 138 2 493 502 1:CAS:528:DC%2BC3cXivVCnsr8%3D 10.1053/j.gastro.2009.10.031 19852963 This paper clearly shows that AFP and DCP are ineffective as surveillance tools for HCC
18. JA Marrero Z Feng Y Wang, et al. 2009 Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma Gastroenterology. 137 1 110 8 1:CAS:528:DC%2BD1MXovFOgsbs%3D 10.1053/j.gastro.2009.04.005 19362088
19. DY Kim KH Han SH Ahn, et al. 2007 Semiannual surveillance for hepatocellular carcinoma improved patient survival compared to annual surveillance (Korean experience) Hepatology 46 Suppl. 1 403A
20. S Saab D Ly J Nieto, et al. 2003 Hepatocellular Carcinoma Screening in Patients Waiting for Liver Transplantation: A Decision Analytic Model Liver Transplantation 9 7 672 681 10.1053/jlts.2003.50120 12827551 (Pubitemid 36874452)
21. A Forner R Vilana C Ayuso, et al. 2008 Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma Hepatology 47 1 97 104 10.1002/hep.21966 18069697 (Pubitemid 351171046)
22. Sangiovanni A, Manini MA, Iavarone M, et al. The diagnostic and economic impact of contrast imaging technique in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut. 2009 Dec 1.
23. Khalili K, Kim TY, Jang HJ, et al. Implementation of AASLD hepatocellular carcinoma practice guidelines in North America: two years of experience. In press J Hepatol.
24. J Rimola A Forner M Reig, et al. 2009 Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma Hepatology. 50 3 791 8 10.1002/hep.23071 19610049
25. American Association for Study of Liver Disease website. Available at http://www.aasld.org/practiceguidelines/Documents/ Bookmarked%20Practice%20Guidelines/HCCUpdate2010.pdf (Accessed July 28 2010)
26. The International Consensus Group for Hepatocellular Neoplasia 2009 Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia Hepatology 49 2 658 664 10.1002/hep.22709 This is an important paper because it describes for the first time the standardization of nomenclature for early HCC and pre-neoplastic lesions. Now East and West can speak the same language
27. L Di Tommaso G Franchi YN Park, et al. 2007 Diagnostic value of HSP70, glypican 3 and glutamine synthetase in hepatocellular nodules in cirrhosis Hepatology 45 725 734 10.1002/hep.21531 17326147 (Pubitemid 46450624)
28. T Livraghi F Meloni SM Di, et al. 2008 Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 47 1 82 89 10.1002/hep.21933 18008357 (Pubitemid 351171044)
29. Y Hoshida SM Nijman M Kobayashi, et al. 2009 Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma Cancer Res. 69 18 7385 92 1:CAS:528:DC%2BD1MXhtFaku7vN 10.1158/0008-5472.CAN-09- 1089 19723656
30. P Laurent-Puig P Legoix O Bluteau, et al. 2006 Genetic alterations associated with hepatocellular carcinoma define distinc pathways of hepatocarcinogenesis Hepatology 43 2 suppl1 S145 S150
31. S Boyault DS Rickman A de Renies, et al. 2007 Transcriptome classification of HCC is related to gene alteration and to new therapeutic targets Hepatology 45 42 52 1:CAS:528:DC%2BD2sXht1arsb4%3D 10.1002/hep.21467 17187432 (Pubitemid 46144363)
32. Y Hoshida A Villanueva M Kobayashi, et al. 2008 Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med. 359 19 1995 2004 1:CAS:528:DC%2BD1cXhtleisrzE 10.1056/NEJMoa0804525 18923165
33. J Bruix JM Llovet 2002 Prognostic prediction and treatment strategy in HCC Hepatology 35 519 524 10.1053/jhep.2002.32089 11870363 (Pubitemid 34183954)
34. JN Vauthey GY Lauwers NF Esnaola, et al. 2002 Simplified staging for hepatocellular carcinoma J Clin Oncol. 20 6 1527 36 10.1200/JCO.20.6.1527 11896101 (Pubitemid 34260532)
35. GN Ioannou JD Perkins RL Carithers Jr 2008 Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival Gastroenterology. 134 5 1342 51 10.1053/j.gastro.2008.02.013 18471511 (Pubitemid 351615357)
36. M Kudo H Chung Y Osaki 2003 Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) J Gastroenterol 38 207 215 10.1007/s005350300038 12673442 (Pubitemid 36527122)